NewEdge Advisors’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.73M | Buy |
77,501
+12,172
| +19% | +$568K | 0.01% | 804 |
|
|
2025
Q4 | $3.17M | Buy |
65,329
+996
| +2% | +$49.4K | 0.01% | 845 |
|
|
2025
Q3 | $3.04M | Sell |
64,333
-666,875
| -91% | -$32.2M | 0.01% | 820 |
|
|
2025
Q2 | $35.3M | Buy |
731,208
+693,770
| +1,853% | +$35.4M | 0.18% | 113 |
|
|
2025
Q1 | $2.08M | Buy |
37,438
+642
| +2% | +$34.8K | 0.01% | 848 |
|
|
2024
Q4 | $1.77M | Buy |
36,796
+5,958
| +19% | +$303K | 0.01% | 875 |
|
|
2024
Q3 | $1.78M | Buy |
30,838
+1,251
| +4% | +$67.5K | 0.01% | 844 |
|
|
2024
Q2 | $1.44M | Buy |
29,587
+6,330
| +27% | +$305K | 0.01% | 904 |
|
|
2024
Q1 | $1.13M | Sell |
23,257
-3,824
| -14% | -$187K | 0.01% | 948 |
|
|
2023
Q4 | $1.35M | Sell |
27,081
-20,122
| -43% | -$984K | 0.01% | 815 |
|
|
2023
Q3 | $2.53M | Sell |
47,203
-21,614
| -31% | -$1.15M | 0.03% | 525 |
|
|
2023
Q2 | $3.71M | Buy |
68,817
+29,067
| +73% | +$1.56M | 0.04% | 394 |
|
|
2023
Q1 | $2.16M | Buy |
39,750
+10,679
| +37% | +$519K | 0.03% | 514 |
|
|
2022
Q4 | $705K | Sell |
29,071
-984
| -3% | -$43.2K | 0.02% | 639 |
|
|
2022
Q3 | $1.14M | Buy |
30,055
+103
| +0.3% | +$4.59K | 0.02% | 600 |
|
|
2022
Q2 | $1.5M | Sell |
29,952
-987
| -3% | -$52.4K | 0.02% | 520 |
|
|
2022
Q1 | $1.59M | Buy |
30,939
+916
| +3% | +$47.3K | 0.03% | 486 |
|
|
2021
Q4 | $1.5M | Buy |
30,023
+15,726
| +110% | +$778K | 0.02% | 547 |
|
|
2021
Q3 | $689K | Sell |
14,297
-202
| -1% | -$10.3K | 0.02% | 656 |
|
|
2021
Q2 | $763K | Buy |
14,499
+397
| +3% | +$20.7K | 0.02% | 598 |
|
|
2021
Q1 | $698K | Sell |
14,102
-17,206
| -55% | -$827K | 0.02% | 567 |
|
|
2020
Q4 | $1.52M | Sell |
31,308
-334,873
| -91% | -$16.5M | 0.05% | 310 |
|
|
2020
Q3 | $18.4M | Buy |
366,181
+20,887
| +6% | +$1.08M | 0.64% | 38 |
|
|
2020
Q2 | $17.6M | Buy |
345,294
+331,140
| +2,340% | +$16.1M | 0.69% | 39 |
|
|
2020
Q1 | $619K | Buy |
14,154
+6,046
| +75% | +$289K | 0.03% | 409 |
|
|
2019
Q4 | $407K | Buy |
8,108
+308
| +4% | +$14.4K | 0.02% | 583 |
|
|
2019
Q3 | $361K | Sell |
7,800
-10
| -0.1% | -$431 | 0.02% | 591 |
|
|
2019
Q2 | $338K | Buy |
7,810
+277
| +4% | +$11.8K | 0.02% | 497 |
|
|
2019
Q1 | $334K | Buy |
7,533
+1,402
| +23% | +$60.1K | 0.02% | 495 |
|
|
2018
Q4 | $266 | Buy |
6,131
+369
| +6% | +$16.3K | 0.02% | 518 |
|
|
2018
Q3 | $257K | Sell |
5,762
-206
| -3% | -$8.8K | 0.02% | 536 |
|
|
2018
Q2 | $239 | Buy |
5,968
+877
| +17% | +$34.5K | 0.02% | 467 |
|
|
2018
Q1 | $201K | Buy |
+5,091
| New | +$212K | 0.02% | 472 |
|
|
2017
Q3 | – | Sell |
-3,280
| Closed | -$156K | – | 1010 |
|
|
2017
Q2 | $156K | Buy |
+3,280
| New | +$157K | 0.03% | 356 |
|
Other funds holding SNY
MIP
NewEdge Advisors's SNY Position: Q1 2026 in Review
NewEdge Advisors increased its Sanofi (SNY) stake by 19% in Q1 2026, buying an estimated $568K and bringing the position to 77,501 shares worth $3.73M. The position accounts for 0.01% of the portfolio, ranked #804.
NewEdge Advisors first reported a position in SNY in Q2 2017 and has held it in 34 quarters since. The position peaked at $35.3M in Q2 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.
- NewEdge Advisors held 77,501 shares of Sanofi worth $3.73M as of Q1 2026.
- NewEdge Advisors bought 12,172 Sanofi shares in Q1 2026, an estimated $568K.
- Sanofi made up 0.01% of NewEdge Advisors's portfolio in Q1 2026, its #804 holding.
- NewEdge Advisors first reported a position in Sanofi in Q2 2017 and has held it in 34 quarters since.
- NewEdge Advisors's Sanofi position peaked at $35.3M in Q2 2025.
- 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.
Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.